- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/17 - Lymphocytes; Lymphocytes B; Lymphocytes T; Cellules tueuses naturelles; Lymphocytes activés par un interféron ou une cytokine
Détention brevets de la classe A61K 35/17
Brevets de cette classe: 11214
Historique des publications depuis 10 ans
|
183
|
422
|
584
|
819
|
1232
|
1514
|
1724
|
1922
|
1450
|
416
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
485 |
| The Trustees of the University of Pennsylvania | 4122 |
262 |
| The Regents of the University of California | 18943 |
250 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
203 |
| Iovance Biotherapeutics, Inc. | 301 |
199 |
| Board of Regents, The University of Texas System | 5370 |
194 |
| Juno Therapeutics, Inc. | 365 |
149 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
137 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
129 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
101 |
| City of Hope | 943 |
97 |
| Autolus Limited | 232 |
94 |
| Cellectis | 397 |
94 |
| The General Hospital Corporation | 4517 |
92 |
| Baylor College of Medicine | 875 |
92 |
| Novartis AG | 11238 |
89 |
| Kite Pharma, Inc. | 315 |
85 |
| Fred Hutchinson Cancer Center | 376 |
82 |
| Regents of the University of Minnesota | 2620 |
80 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
79 |
| Autres propriétaires | 8221 |